---
document_datetime: 2025-12-29 14:34:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/grepid.html
document_name: grepid.html
version: success
processing_time: 0.1393122
conversion_datetime: 2025-12-30 02:03:37.511836
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Grepid

[RSS](/en/individual-human-medicine.xml/65751)

##### Authorised

This medicine is authorised for use in the European Union

clopidogrel Medicine Human Authorised

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Grepid](#more-information-on-grepid-1080)
- [Product information - with tracked changes](#product-information-with-tracked-changes-77512)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine.

If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis for the CHMP recommendations, read the scientific discussion (also part of the EPAR).

Expand section

Collapse section

## What is Grepid?

Grepid is a medicine that contains the active substance clopidogrel. It is available as pink tablets (75 mg).

Grepid is a 'generic medicine'. This means that Grepid is similar to a 'reference medicine' already authorised in the European Union (EU) called Plavix.

## What is Grepid used for?

Grepid is used in adults to prevent atherothrombotic events (problems caused by blood clots and hardening of the arteries). Grepid can be given to the following groups of patients:

- patients who have recently had a myocardial infarction (heart attack). Grepid can be started between a few days and 35 days after the attack;
- patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain). Grepid can be started between seven days and six months after the stroke;
- patients with peripheral arterial disease (problems with blood flow in the arteries).

The medicine can only be obtained with a prescription.

## How is Grepid used?

The standard dose of Grepid is one 75 mg tablet once a day, taken with or without food.

## How does Grepid work?

The active substance in Grepid, clopidogrel, is an inhibitor of platelet aggregation. This means that it helps to prevent blood clots from forming. When the blood clots, this is due to special cells in the blood called platelets aggregating (sticking together).

Clopidogrel stops the platelets aggregating by blocking a substance called ADP from attaching to a special receptor on their surface. This stops the platelets becoming 'sticky', reducing the risk of a blood clot forming and helping to prevent another heart attack or stroke.

## How has Grepid been studied?

Because Grepid is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Plavix. Two medicines are bioequivalent when they produce the same levels of the active substance in the body.

## What are the benefit and risk of Grepid?

Because Grepid is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as those of the reference medicine.

## Why has Grepid been approved?

The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Grepid has been shown to have comparable quality and to be bioequivalent to Plavix. Therefore, the CHMP's view was that, as for Plavix, the benefit outweighs the identified risk. The Committee recommended that Grepid be given marketing authorisation.

## Other information about Grepid

The European Commission granted a marketing authorisation valid throughout the EU for Grepid to Pharmathen S.A. on 28 July 2009.

Grepid : EPAR - Summary for the public

English (EN) (40.79 KB - PDF)

**First published:** 05/08/2009

**Last updated:** 05/08/2009

[View](/en/documents/overview/grepid-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-813)

български (BG) (161.48 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/bg/documents/overview/grepid-epar-summary-public_bg.pdf)

español (ES) (41.93 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/es/documents/overview/grepid-epar-summary-public_es.pdf)

čeština (CS) (154.12 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/cs/documents/overview/grepid-epar-summary-public_cs.pdf)

dansk (DA) (41.75 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/da/documents/overview/grepid-epar-summary-public_da.pdf)

Deutsch (DE) (42.35 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/de/documents/overview/grepid-epar-summary-public_de.pdf)

eesti keel (ET) (41.47 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/et/documents/overview/grepid-epar-summary-public_et.pdf)

ελληνικά (EL) (170.9 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/el/documents/overview/grepid-epar-summary-public_el.pdf)

français (FR) (41.95 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/fr/documents/overview/grepid-epar-summary-public_fr.pdf)

italiano (IT) (41.83 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/it/documents/overview/grepid-epar-summary-public_it.pdf)

latviešu valoda (LV) (149.39 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/lv/documents/overview/grepid-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (150.17 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/lt/documents/overview/grepid-epar-summary-public_lt.pdf)

magyar (HU) (145.45 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/hu/documents/overview/grepid-epar-summary-public_hu.pdf)

Malti (MT) (153.77 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/mt/documents/overview/grepid-epar-summary-public_mt.pdf)

Nederlands (NL) (41.7 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/nl/documents/overview/grepid-epar-summary-public_nl.pdf)

polski (PL) (159.72 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/pl/documents/overview/grepid-epar-summary-public_pl.pdf)

português (PT) (41.98 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/pt/documents/overview/grepid-epar-summary-public_pt.pdf)

română (RO) (143.5 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/ro/documents/overview/grepid-epar-summary-public_ro.pdf)

slovenčina (SK) (150.23 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/sk/documents/overview/grepid-epar-summary-public_sk.pdf)

slovenščina (SL) (110.77 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/sl/documents/overview/grepid-epar-summary-public_sl.pdf)

Suomi (FI) (41.51 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/fi/documents/overview/grepid-epar-summary-public_fi.pdf)

svenska (SV) (41.6 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

05/08/2009

[View](/sv/documents/overview/grepid-epar-summary-public_sv.pdf)

Grepid : EPAR - Risk management plan

English (EN) (758.3 KB - PDF)

**First published:** 12/12/2024

[View](/en/documents/rmp/grepid-epar-risk-management-plan_en.pdf)

## Product information

Grepid : EPAR - Product Information

English (EN) (549.59 KB - PDF)

**First published:** 13/10/2009

**Last updated:** 23/06/2025

[View](/en/documents/product-information/grepid-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-543)

български (BG) (672.44 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/bg/documents/product-information/grepid-epar-product-information_bg.pdf)

español (ES) (543.22 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/es/documents/product-information/grepid-epar-product-information_es.pdf)

čeština (CS) (584.11 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/cs/documents/product-information/grepid-epar-product-information_cs.pdf)

dansk (DA) (508.46 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/da/documents/product-information/grepid-epar-product-information_da.pdf)

Deutsch (DE) (506.02 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/de/documents/product-information/grepid-epar-product-information_de.pdf)

eesti keel (ET) (479.65 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/et/documents/product-information/grepid-epar-product-information_et.pdf)

ελληνικά (EL) (628.24 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/el/documents/product-information/grepid-epar-product-information_el.pdf)

français (FR) (710.67 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/fr/documents/product-information/grepid-epar-product-information_fr.pdf)

hrvatski (HR) (522.21 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/hr/documents/product-information/grepid-epar-product-information_hr.pdf)

íslenska (IS) (570.34 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/is/documents/product-information/grepid-epar-product-information_is.pdf)

italiano (IT) (546.06 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/it/documents/product-information/grepid-epar-product-information_it.pdf)

latviešu valoda (LV) (517.39 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/lv/documents/product-information/grepid-epar-product-information_lv.pdf)

lietuvių kalba (LT) (596.6 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/lt/documents/product-information/grepid-epar-product-information_lt.pdf)

magyar (HU) (548.46 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/hu/documents/product-information/grepid-epar-product-information_hu.pdf)

Malti (MT) (597.44 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/mt/documents/product-information/grepid-epar-product-information_mt.pdf)

Nederlands (NL) (542.36 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/nl/documents/product-information/grepid-epar-product-information_nl.pdf)

norsk (NO) (494.24 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/no/documents/product-information/grepid-epar-product-information_no.pdf)

polski (PL) (484.96 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/pl/documents/product-information/grepid-epar-product-information_pl.pdf)

português (PT) (519.81 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/pt/documents/product-information/grepid-epar-product-information_pt.pdf)

română (RO) (492.41 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/ro/documents/product-information/grepid-epar-product-information_ro.pdf)

slovenčina (SK) (531.42 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/sk/documents/product-information/grepid-epar-product-information_sk.pdf)

slovenščina (SL) (541.81 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/sl/documents/product-information/grepid-epar-product-information_sl.pdf)

Suomi (FI) (510.71 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/fi/documents/product-information/grepid-epar-product-information_fi.pdf)

svenska (SV) (544.92 KB - PDF)

**First published:**

13/10/2009

**Last updated:**

23/06/2025

[View](/sv/documents/product-information/grepid-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0000280379 20/06/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Grepid : EPAR - All Authorised presentations

English (EN) (15.96 KB - PDF)

**First published:** 05/08/2009

**Last updated:** 14/06/2023

[View](/en/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-867)

български (BG) (95.48 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/bg/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_bg.pdf)

español (ES) (87.04 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/es/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_es.pdf)

čeština (CS) (91.42 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/cs/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (49.48 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/da/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (50.21 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/de/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (88.72 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/et/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (92.05 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/el/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_el.pdf)

français (FR) (92.2 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/fr/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (92.97 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/hr/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (96 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/is/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_is.pdf)

italiano (IT) (15.68 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/it/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (91.49 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/lv/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (92.52 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/lt/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (96.63 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/hu/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (93.54 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/mt/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (15.72 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/nl/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (49.55 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/no/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_no.pdf)

polski (PL) (50.79 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/pl/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_pl.pdf)

português (PT) (88.37 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/pt/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_pt.pdf)

română (RO) (90.75 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/ro/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (91.47 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/sk/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (90.6 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/sl/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (88.63 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/fi/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (89.49 KB - PDF)

**First published:**

05/08/2009

**Last updated:**

14/06/2023

[View](/sv/documents/all-authorised-presentations/grepid-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Grepid Active substance clopidogrel (as besilate) International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH)

- Peripheral Vascular Diseases
- Stroke
- Myocardial Infarction

Anatomical therapeutic chemical (ATC) code B01AC04

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

**Prevention of atherothrombotic events**

Clopidogrel is indicated in:

- adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;
- adult patients suffering from acute coronary syndrome:
    - non-ST-segment-elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA);
    - ST-segment-elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

**Prevention of atherothrombotic and thromboembolic events in atrial fibrillation**

In adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin-K antagonists and who have a low bleeding risk, clopidogrel is indicated in combination with ASA for the prevention of atherothrombotic and thromboembolic events, including stroke.

## Authorisation details

EMA product number EMEA/H/C/001059

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Pharmathen S.A.

6, Dervenakion str.

Opinion adopted 29/05/2009 Marketing authorisation issued 27/07/2009 Revision 29

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Grepid : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (173.12 KB - PDF)

**First published:** 23/06/2025

[View](/en/documents/procedural-steps-after/grepid-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Grepid : EPAR - Procedural steps taken and scientific information after authorisation (archive)

English (EN) (228.74 KB - PDF)

**First published:** 13/10/2009

**Last updated:** 23/06/2025

[View](/en/documents/procedural-steps-after/grepid-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf)

## Initial marketing authorisation documents

Grepid : EPAR - Public assessment report

English (EN) (220.29 KB - PDF)

**First published:** 05/08/2009

**Last updated:** 05/08/2009

[View](/en/documents/assessment-report/grepid-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Grepid

Reference Number: EMEA/CHMP/310253/2009

English (EN) (33.1 KB - PDF)

**First published:** 29/05/2009

**Last updated:** 29/05/2009

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-grepid_en.pdf)

#### More information on Grepid

Questions and answers on generic medicines

Reference Number: EMA/393905/2006 Rev. 2

English (EN) (66.45 KB - PDF)

**First published:** 09/07/2007

**Last updated:** 07/12/2012

[View](/en/documents/other/questions-and-answers-generic-medicines_en.pdf)

[Other languages (22)](#file-language-dropdown-573)

български (BG) (93.16 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/bg/documents/other/questions-and-answers-generic-medicines_bg.pdf)

español (ES) (68.3 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/es/documents/other/questions-and-answers-generic-medicines_es.pdf)

čeština (CS) (87.71 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/cs/documents/other/questions-and-answers-generic-medicines_cs.pdf)

dansk (DA) (66.79 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/da/documents/other/questions-and-answers-generic-medicines_da.pdf)

Deutsch (DE) (67.55 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/de/documents/other/questions-and-answers-generic-medicines_de.pdf)

eesti keel (ET) (65.21 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/et/documents/other/questions-and-answers-generic-medicines_et.pdf)

ελληνικά (EL) (91.29 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/el/documents/other/questions-and-answers-generic-medicines_el.pdf)

français (FR) (68.35 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/fr/documents/other/questions-and-answers-generic-medicines_fr.pdf)

hrvatski (HR) (87.8 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/hr/documents/other/questions-and-answers-generic-medicines_hr.pdf)

italiano (IT) (67.62 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/it/documents/other/questions-and-answers-generic-medicines_it.pdf)

latviešu valoda (LV) (111.81 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/lv/documents/other/questions-and-answers-generic-medicines_lv.pdf)

lietuvių kalba (LT) (86.76 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/lt/documents/other/questions-and-answers-generic-medicines_lt.pdf)

magyar (HU) (85.76 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/hu/documents/other/questions-and-answers-generic-medicines_hu.pdf)

Malti (MT) (89.35 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/mt/documents/other/questions-and-answers-generic-medicines_mt.pdf)

Nederlands (NL) (66.81 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/nl/documents/other/questions-and-answers-generic-medicines_nl.pdf)

polski (PL) (88.51 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/pl/documents/other/questions-and-answers-generic-medicines_pl.pdf)

português (PT) (68.32 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/pt/documents/other/questions-and-answers-generic-medicines_pt.pdf)

română (RO) (86.9 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/ro/documents/other/questions-and-answers-generic-medicines_ro.pdf)

slovenčina (SK) (87.73 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sk/documents/other/questions-and-answers-generic-medicines_sk.pdf)

slovenščina (SL) (84.8 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sl/documents/other/questions-and-answers-generic-medicines_sl.pdf)

Suomi (FI) (66.21 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/fi/documents/other/questions-and-answers-generic-medicines_fi.pdf)

svenska (SV) (67.11 KB - PDF)

**First published:**

09/07/2007

**Last updated:**

07/12/2012

[View](/sv/documents/other/questions-and-answers-generic-medicines_sv.pdf)

#### Product information - with tracked changes

The approved product information for this medicine is available below showing the changes since the previous procedure affecting the product information. The same document without tracked changes is above under 'Product information'.

Grepid : EPAR - Product information - tracked changes

English (EN) (329.5 KB - DOC)

**First published:** 23/06/2025

[View](/en/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_en.doc)

[Other languages (24)](#file-language-dropdown-816)

български (BG) (489 KB - DOC)

**First published:**

23/06/2025

[View](/bg/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_bg.doc)

español (ES) (339 KB - DOC)

**First published:**

23/06/2025

[View](/es/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_es.doc)

čeština (CS) (437.5 KB - DOC)

**First published:**

23/06/2025

[View](/cs/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_cs.doc)

dansk (DA) (344.5 KB - DOC)

**First published:**

23/06/2025

[View](/da/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_da.doc)

Deutsch (DE) (360.5 KB - DOC)

**First published:**

23/06/2025

[View](/de/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_de.doc)

eesti keel (ET) (112.17 KB - DOCX)

**First published:**

23/06/2025

[View](/et/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_et.docx)

ελληνικά (EL) (469.5 KB - DOC)

**First published:**

23/06/2025

[View](/el/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_el.doc)

français (FR) (330.5 KB - DOC)

**First published:**

23/06/2025

[View](/fr/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_fr.doc)

hrvatski (HR) (475.5 KB - DOC)

**First published:**

23/06/2025

[View](/hr/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_hr.doc)

íslenska (IS) (356 KB - DOC)

**First published:**

23/06/2025

[View](/is/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_is.doc)

italiano (IT) (378 KB - DOC)

**First published:**

23/06/2025

[View](/it/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_it.doc)

latviešu valoda (LV) (461 KB - DOC)

**First published:**

23/06/2025

[View](/lv/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_lv.doc)

lietuvių kalba (LT) (441 KB - DOC)

**First published:**

23/06/2025

[View](/lt/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_lt.doc)

magyar (HU) (435 KB - DOC)

**First published:**

23/06/2025

[View](/hu/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_hu.doc)

Malti (MT) (468.5 KB - DOC)

**First published:**

23/06/2025

[View](/mt/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_mt.doc)

Nederlands (NL) (484.5 KB - DOC)

**First published:**

23/06/2025

[View](/nl/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_nl.doc)

norsk (NO) (140.11 KB - DOCX)

**First published:**

23/06/2025

[View](/no/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_no.docx)

polski (PL) (477.5 KB - DOC)

**First published:**

23/06/2025

[View](/pl/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_pl.doc)

português (PT) (357.5 KB - DOC)

**First published:**

23/06/2025

[View](/pt/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_pt.doc)

română (RO) (130.59 KB - DOCX)

**First published:**

23/06/2025

[View](/ro/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_ro.docx)

slovenčina (SK) (436.5 KB - DOC)

**First published:**

23/06/2025

[View](/sk/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_sk.doc)

slovenščina (SL) (436.5 KB - DOC)

**First published:**

23/06/2025

[View](/sl/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_sl.doc)

Suomi (FI) (367 KB - DOC)

**First published:**

23/06/2025

[View](/fi/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_fi.doc)

svenska (SV) (115.17 KB - DOCX)

**First published:**

23/06/2025

[View](/sv/documents/product-information-tracked-changes/grepid-epar-product-information-tracked-changes_sv.docx)

#### Topics

- [Generic and hybrid medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A54)
- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 23/06/2025

## Share this page

[Back to top](#main-content)